Subscribe to Newsletter
Subspecialties Retina

Ahmed ClearPath®

sponsored by New World Medical

As a leading innovation in glaucoma treatment, developed by New World Medical, the Ahmed ClearPath is a clear choice for ophthalmologists seeking effective, non-valved implant solutions for intraocular pressure (IOP) management. With its thoughtful design and convenient features, the device supports both efficient surgical implantation and long-term patient outcomes (1).

Innovative design for reliable IOP control
 

The Ahmed Clear Path introduces an innovative solution for non-valved glaucoma drainage devices, providing surgeons with precise control over IOP management. Its flexible plate material and low-lying profile are designed to promote the formation of a low diffuse bleb, enhancing IOP stability over the long term (2).

Single-quadrant implantation for surgical convenience
 

Designed with convenience in mind, the Ahmed ClearPath is available in two sizes: 250 mm2 and 350 mm2. The 250mm2 model facilitates a true single-quadrant implantation between the rectus muscles, eliminating the need for muscle isolation, streamlining the procedure and simplifying positioning. Meanwhile the 350mm2 model features a winged design that stabilizes beneath the rectus muscles without direct attachment, further supporting stable positioning. This range of options provides surgeons with the flexibility to select the best fit for each patient’s needs and reduce the surgical complexity associated with overall implant placement.

Thoughtful features for enhanced surgical efficiency
 

The Ahmed ClearPath’s all-inclusive packaging includes a 23-gauge needle and a pre-threaded 4-0 Prolene ripcord suture, making it convenient and ready for use right out of the box. Additionally, the inclusion of anterior suture holes allows for precise fixation and improved access, giving surgeons added control and positioning accuracy during implantation.

The Ahmed ClearPath represents a clear choice for non-valved glaucoma drainage devices, setting new standards and combining innovation with practical design for a device that both surgeons and patients can rely on.

NEWS

The Ophthalmologist Presents:

The Ophthalmologist Weekly Newsletter

Enjoying yourself? There's plenty more where that came from! Our weekly newsletter from The Ophthalmologist brings you the most popular stories as they unfold, chosen by our fantastic Editorial team!

Register for our weekly newsletter

Receive content, products, events as well as relevant industry updates from The Ophthalmologist and its sponsors.

When you click “Subscribe” we will email you a link, which you must click to verify the email address above and activate your subscription. If you do not receive this email, please contact us at [email protected].
If you wish to unsubscribe, you can update your preferences at any point.

  1. WS Shalaby et al., “Ahmed ClearPath vs. Baerveldt Glaucoma Implant: A Retrospective Noninferiority Comparative Study,” Ophthalmol Glaucoma, 7, 251 (2024). PMID: 38158079.
  2. RC Barão et al., “Bleb morphology of glaucoma drainage devices on magnetic resonance imaging,” Acta Ophthalmol, 101, 789 (2023). PMID: 37066864.
Related Product Profiles
Uncover the Unique DNA of SPECTRALIS®

| Contributed by Heidelberg Engineering

Subspecialties Retina
ForeseeHome® – remote monitoring to help detect wet AMD earlier and improve outcomes

| Contributed by Notal Vision

Product Profiles

Access our product directory to see the latest products and services from our industry partners

Here
Most Popular
Register to The Ophthalmologist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Ophthalmologist magazine

Register

Disclaimer

The Ophthalmologist website is intended solely for the eyes of healthcare professionals. Please confirm below: